Latest news on DaliRasen in 2025: price, medical insurance and clinical progress

As a new type of insomnia treatment drug, daridorexant mainly acts on orexin receptors and can help improve patients' sleep quality. It is especially suitable for adult insomnia patients who face difficulty falling asleep or maintaining sleep. Currently, this drug has been approved in some international markets and is undergoing verification in various clinical trials. However, for the Chinese market, DaliRasen is still not approved for marketing, and patients can only obtain this drug through overseas channels.

In overseas markets, especially Europe and the United States, Dali Rayson has entered formal channels and has achieved relatively stable sales. According to the latest market trends, the price of the European version of Dali’s original drug is approximately 50 mg × 30 tablets per box, which is about more than 2,000 yuan. It should be noted that due to fluctuations in international exchange rates, specific prices may fluctuate. In addition, although this drug is already available in foreign markets, there is currently no generic version of DaliRasen on the market, which makes its price relatively high and limits the purchasing power of some patients.

Regarding the medical insurance policy, DaliRasen is currently not included in China’s medical insurance catalog, which means that domestic patients cannot enjoy medical insurance reimbursement. Nonetheless, as clinical data on the treatment of insomnia with this type of drug increases, it remains to be seen whether relevant departments will consider including it in medical insurance in the future.

Judging from clinical progress, DaliRasen has shown significant efficacy in the treatment of insomnia. In multiple clinical trials, patients have experienced significant improvements in shortening sleep latency, increasing total sleep time, and reducing the number of nighttime awakenings after taking the drug. Compared with traditional insomnia treatment drugs, DaliRasen has become an emerging choice for the treatment of insomnia due to its lower risk of side effects and better tolerability.

Reference materials:https://www.quviviq.com/